Science Explorer Back to mapMap
Discussion
Researcher · Angiogenesis Foundation · United States

John Brady Ridgway

John Brady Ridgway publishes mostly in Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology, on topics such as Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research and Angiogenesis and VEGF in Cancer.

OpenAlex
World rank
#861,473
of 7,710,434 ranked researchers
Rank in United States
#285,309
of 1,627,098
Works
25
Citations
6.2k
Citations per work
246.4
h-index
18
i10-index 20Top 39% in Molecular Biology
John Brady Ridgway

What does John Brady Ridgway research?

John Brady Ridgway's work is mostly in Biochemistry, Genetics and Molecular Biology (52%), Medicine (29%), Immunology and Microbiology (5%).

Life Sciences: 14 works · 57.2% of their workBiochemistry, Genetics and Molecular Biology: 13 works · 52.4% of their workMolecular Biology: 12 works · 47.6% of their workCell Biology: 1 works · 4.8% of their workImmunology and Microbiology: 1 works · 4.8% of their workImmunology: 1 works · 4.8% of their workHealth Sciences: 7 works · 28.6% of their workMedicine: 7 works · 28.6% of their workRadiology, Nuclear Medicine and Imaging: 4 works · 15.9% of their workOncology: 2 works · 7.9% of their workPhysiology: 1 works · 4.8% of their workEverything else: 4 works · 14.2% of their workTHEIR WORKJohn BradyRidgway25works
Life Sciences57%Health Sciences29%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1352.4%
    2. Immunology and Microbiology14.8%
    1. Medicine728.6%
  3. Everything else414.2%
  1. 1Molecular Biology48% of their works
  2. 2Radiology, Nuclear Medicine and Imaging16% of their works
  3. 3Oncology8% of their works
  4. 4Immunology5% of their works
  5. 5Physiology5% of their works
  6. 6Cell Biology5% of their works

Research topics

Which keywords describe John Brady Ridgway's research?

The keywords of their largest research topics: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Cancer, endothelial progenitor cells and Glycans.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Glycosylation132 topics
  2. Monoclonal Antibodies112 topics
  3. Therapeutic Antibodies112 topics
  4. Antibody Engineering81 topic
  5. Fc Receptors81 topic
  6. Cancer51 topic
  7. Glycans51 topic
  8. VEGF51 topic
  9. endothelial progenitor cells51 topic
  10. Biopharmaceuticals31 topic
  11. Cardiomyocyte Renewal31 topic
  12. Development31 topic
  13. Drug Discovery31 topic
  14. Heart Regeneration31 topic
  15. Notch Signaling31 topic
  16. Peptide Synthesis31 topic
  17. Protein Aggregation31 topic
  18. Lymphangiogenesis21 topic
  19. VEGF-C21 topic

Where does John Brady Ridgway work?

John Brady Ridgway's main affiliation in the publication record is Angiogenesis Foundation, United States.

How many publications and citations does John Brady Ridgway have?

OpenAlex counts 25 works and 6,159 citations for John Brady Ridgway, an h-index of 18, ranking #861,473 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about John Brady Ridgway. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.